Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.

Klar AS, Gopinadh J, Kleber S, Wadle A, Renner C.

PLoS One. 2015 Oct 8;10(10):e0139221. doi: 10.1371/journal.pone.0139221. eCollection 2015.

2.

RP1 is a phosphorylation target of CK2 and is involved in cell adhesion.

Stenner F, Liewen H, Göttig S, Henschler R, Markuly N, Kleber S, Faust M, Mischo A, Bauer S, Zweifel M, Knuth A, Renner C, Wadle A.

PLoS One. 2013 Jul 3;8(7):e67595. doi: 10.1371/journal.pone.0067595. Print 2013.

3.

Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.

Fischer E, Chaitanya K, Wüest T, Wadle A, Scott AM, van den Broek M, Schibli R, Bauer S, Renner C.

Clin Cancer Res. 2012 Nov 15;18(22):6208-18. doi: 10.1158/1078-0432.CCR-12-0644. Epub 2012 Sep 19.

4.

Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.

Schuberth PC, Jakka G, Jensen SM, Wadle A, Gautschi F, Haley D, Haile S, Mischo A, Held G, Thiel M, Tinguely M, Bifulco CB, Fox BA, Renner C, Petrausch U.

Gene Ther. 2013 Apr;20(4):386-95. doi: 10.1038/gt.2012.48. Epub 2012 Jun 28.

PMID:
22739387
5.

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.

Payeli SK, Kollnberger S, Marroquin Belaunzaran O, Thiel M, McHugh K, Giles J, Shaw J, Kleber S, Ridley A, Wong-Baeza I, Keidel S, Kuroki K, Maenaka K, Wadle A, Renner C, Bowness P.

Arthritis Rheum. 2012 Oct;64(10):3139-49. doi: 10.1002/art.34538.

6.

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis.

Mischo A, Bubel N, Cebon JS, Samaras P, Petrausch U, Stenner-Liewen F, Schaefer NG, Kubuschok B, Renner C, Wadle A.

Int J Oncol. 2011 Jul;39(1):287-94. doi: 10.3892/ijo.2011.1032. Epub 2011 May 6.

PMID:
21573493
7.

NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.

Wadle A, Mischo A, Strahl S, Nishikawa H, Held G, Neumann F, Wullner B, Fischer E, Kleber S, Karbach J, Jager E, Shiku H, Odunsi K, Shrikant PA, Knuth A, Cerundolo V, Renner C.

Yeast. 2010 Nov;27(11):919-31. doi: 10.1002/yea.1796.

8.

Cryptic epitopes induce high-titer humoral immune response in patients with cancer.

Fischer E, Kobold S, Kleber S, Kubuschok B, Braziulis E, Knuth A, Renner C, Wadle A.

J Immunol. 2010 Sep 1;185(5):3095-102. doi: 10.4049/jimmunol.0902166. Epub 2010 Jul 26.

9.

Yeast-based identification of prostate tumor antigens provides an effective vaccine platform.

Jung V, Fischer E, Imig J, Kleber S, Nuber N, Reinshagen F, Kamradt J, Grobholz R, Knuth A, Renner C, Wadle A.

Anticancer Res. 2010 Mar;30(3):895-902.

PMID:
20393012
10.

Rational development of high-affinity T-cell receptor-like antibodies.

Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, Fischer E, Kleber S, Nuber N, Stenner-Liewen F, Bauer S, McMichael A, Knuth A, Abken H, Hombach AA, Cerundolo V, Jones EY, Renner C.

Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5784-8. doi: 10.1073/pnas.0901425106. Epub 2009 Mar 23. Erratum in: Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10872. Nuber, Natko [added].

11.

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, Renner C.

Eur J Immunol. 2007 Jul;37(7):2008-17. Erratum in: Eur J Immunol. 2008 May;38(5):1465-6.

12.

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.

Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Gödde S, Dinges H, Müller-Ladner U, Renner C.

Arthritis Res Ther. 2006;8(6):R171.

13.

Structure-activity profiles of Ab-derived TNF fusion proteins.

Bauer S, Adrian N, Fischer E, Kleber S, Stenner F, Wadle A, Fadle N, Zoellner A, Bernhardt R, Knuth A, Old LJ, Renner C.

J Immunol. 2006 Aug 15;177(4):2423-30.

14.

Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae.

Wadle A, Held G, Neumann F, Kleber S, Wuellner B, Asemissen AM, Kubuschok B, Scheibenbogen C, Breinig T, Meyerhans A, Renner C.

Vaccine. 2006 Sep 11;24(37-39):6272-81. Epub 2006 Jun 14.

PMID:
16860448
15.

Taurine improves epidermal barrier properties stressed by surfactants-a role for osmolytes in barrier homeostasis.

Anderheggen B, Jassoy C, Waldmann-Laue M, Förster T, Wadle A, Doering T.

J Cosmet Sci. 2006 Jan-Feb;57(1):1-10.

PMID:
16676119
16.

Serological immune response to cancer testis antigens in patients with pancreatic cancer.

Wadle A, Kubuschok B, Imig J, Wuellner B, Wittig C, Zwick C, Mischo A, Waetzig K, Romeike BF, Lindemann W, Schilling M, Pfreundschuh M, Renner C.

Int J Cancer. 2006 Jul 1;119(1):117-25.

17.

Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.

Mischo A, Kubuschok B, Ertan K, Preuss KD, Romeike B, Regitz E, Schormann C, de Bruijn D, Wadle A, Neumann F, Schmidt W, Renner C, Pfreundschuh M.

Int J Cancer. 2006 Feb 1;118(3):696-703.

18.

Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity.

Wadle A, Mischo A, Henrich PP, Stenner-Liewen F, Scherer C, Imig J, Petersen G, Pfreundschuh M, Renner C.

Int J Cancer. 2005 Dec 20;117(6):896-904. Erratum in: Int J Cancer. 2007 Sep 15;121(6):1399. Stenner-Lieven, Frank [corrected to Stenner-Liewen, Frank].

19.

Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library.

Wadle A, Mischo A, Imig J, Wüllner B, Hensel D, Wätzig K, Neumann F, Kubuschok B, Schmidt W, Old LJ, Pfreundschuh M, Renner C.

Int J Cancer. 2005 Oct 20;117(1):104-13.

20.

Characterization of the human GARP (Golgi associated retrograde protein) complex.

Liewen H, Meinhold-Heerlein I, Oliveira V, Schwarzenbacher R, Luo G, Wadle A, Jung M, Pfreundschuh M, Stenner-Liewen F.

Exp Cell Res. 2005 May 15;306(1):24-34.

PMID:
15878329
21.

Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.

Mischo A, Wadle A, Wätzig K, Jäger D, Stockert E, Santiago D, Ritter G, Regitz E, Jäger E, Knuth A, Old L, Pfreundschuh M, Renner C.

Cancer Immun. 2003 Jun 27;3:5.

22.

Chromosomal localization and promoter analysis of the adenomatous polyposis coli binding protein RP1.

Wadle A, Thiel G, Mischo A, Jung V, Pfreundschuh M, Renner C.

Oncogene. 2001 Sep 13;20(41):5920-9.

23.

EB/RP gene family encodes tubulin binding proteins.

Juwana JP, Henderikx P, Mischo A, Wadle A, Fadle N, Gerlach K, Arends JW, Hoogenboom H, Pfreundschuh M, Renner C.

Int J Cancer. 1999 Apr 12;81(2):275-84.

24.

Differential mRNA display at the single-cell level.

Renner C, Trümper L, Pfitzenmeier JP, Loftin U, Gerlach K, Stehle I, Wadle A, Pfreundschuh M.

Biotechniques. 1998 May;24(5):720-2, 724. No abstract available.

25.

Calculation of optimum emulsifier mixtures for phase inversion emulsification*.

Förster T, Rybinski WV, Tesmann H, Wadle A.

Int J Cosmet Sci. 1994 Apr;16(2):84-92. doi: 10.1111/j.1467-2494.1994.tb00086.x.

PMID:
19250499

Supplemental Content

Support Center